BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Institute of Oncology
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240831
DTEND;VALUE=DATE:20240901
DTSTAMP:20240808T135947Z
CREATED:20240806T143657Z
LAST-MODIFIED:20240808T135947Z
UID:47571-1725062400-1725148799@www.bricbordeaux.com
SUMMARY:Alpha 1-Antitrypsin deficiency - siRNA treatments - Information meeting
DESCRIPTION:Marion Bouchecareilh\, CR CNRS team 8\, is organizing an information and exchange day for patients with Alpha 1-Antitrypsin deficiency concerning siRNA treatments for the liver damage associated with this deficiency\, on Saturday August 31\, 2024 in Bordeaux (Campus Bordeaux Pey-Berland). The aim of this event\, which will be attended by a number of French experts\, is to present and explain to patients the mode of action of siRNA treatments\, the various clinical trials currently underway and their modalities\, and feedback on this type of treatment for other pathologies. The aim of this meeting is to provide an opportunity for exchange and sharing between patients\, patient associations and the various players involved in understanding and combating the symptoms associated with this deficiency. Program available at this link Hybrid format. Free but mandatory registration before August 15 at this link  Interview with Dr Marion Bouchecareilh for FilFoie\, partner of this event\, available at this link.   \nDr Marion Bouchecareilh presents the rare disease she is studying: Alpha 1-Antitrypsin deficiency\, and the ongoing Phase 3 clinical trial involving siRNA treatment of liver damage associated with this deficiency. She also takes advantage of this interview to talk about the projects she is developing concerning primary hepatopathies and cancers of the liver associated with Alpha 1-Antitrypsin deficiency. Dr Bouchecareilh is leading the latter project in partnership with Dr Samuel Amintas\, MCU-PH also in BRIC team 8.
URL:https://www.bricbordeaux.com/en/event/alpha-1-antitrypsin-deficiency-sirna-treatments-information-meeting/
LOCATION:Pôle Juridique et judiciaire de l’Université de Bordeaux\, 35 place Pey Berland\, Bordeaux\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2024/08/journee-deficit-alpha-1-antitrypsine-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240509T080000
DTEND;TZID=Europe/Paris:20240509T170000
DTSTAMP:20240502T093250Z
CREATED:20240502T093250Z
LAST-MODIFIED:20240502T093250Z
UID:46606-1715241600-1715274000@www.bricbordeaux.com
SUMMARY:The Course du Petit Prince !
DESCRIPTION:On 9 May 2024\, the Course du Petit Prince will take place in the Bourgailh forest\, 160 av. de Beutre 33600 Pessac en Gironde(33). This charity event highlights the fight against sarcomas (malignant tumours that develop in bone and/or soft tissue) by donating all profits to the national RHU CONDOR university hospital research programme. \nTeam 9\, Sarcotarget\, is based at the Institut Bergonié and headed by Antoine Italiano. \nFor young and old alike\, this all-ages run or walk offers trails of 1 or 2 km for children and 7 to 15 km for adults. Safe\, signposted and supervised\, come and have fun while doing a good deed! \nFor further information on the race\, click on the following link:= >https://coursedupetitprince.fr/course
URL:https://www.bricbordeaux.com/en/event/the-course-du-petit-prince/
LOCATION:Bourgailh 160 av. de Beutre 33600 Pessac en Gironde(33)\, 160 av. de Beutre\, Pessac\, 33600\, France
CATEGORIES:Meetings,News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2024/05/course-du-petit-prince.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231118
DTEND;VALUE=DATE:20231119
DTSTAMP:20231114T134548Z
CREATED:20231110T104749Z
LAST-MODIFIED:20231114T134548Z
UID:44954-1700265600-1700351999@www.bricbordeaux.com
SUMMARY:Research opens its doors to you - SBM Department
DESCRIPTION:The Department of Biological and Medical Sciences (SBM) at the University of Bordeaux is opening the doors of its research laboratories to showcase its scientific and technical activities. \n📆 Saturday\, November 18\, 10am to 12:30pm and 2pm to 5pm. \n📌 Bâtiment Bordeaux Biologie Santé (BBS)\, site Carreire Université de Bordeaux : 2 rue du Dr Hoffmann Martinot Bordeaux \nOur Institute for Cancer Research is taking an active part in this day! Here’s what our scientists have to say: \nVISITS: \n🦸‍♀️ “The superpowers of cells”.\nwith Lamia Azzi-Martin (team 4)\, Arnaud Jabouille et Clotilde Billottet (team 3)\, Laura Chaillot (team 1) \n🐸 “Frogs in the service of science”\nwith Sandrine Fedou\, Joudi El Mir (team 5) \n🛸 “Journey to the center of a biopsy”\nwith Alban Giese\, Elodie Sifré\, Christine Varon (team 4) \nPOSTERS \nLamia Azzi-Martin (team 4)\, Laura Chaillot (team 1)\, Sandrine Fedou (team 5)\, Yasmine Pobiedonoscew (team 11)\, Lucile Rouyer (team 3)\, Isabelle Vigon (team 10) \nWORKSHOPS \n🔬Microscopy workshop : Vanessa Desplat (team 10) \n🎭 “Preconceived ideas” workshop : Lucile Rouyer (team 3) \nAnd here are the people in our unit to welcome and guide you:\n \n🏃‍♀️ Marion Bouchecareilh (team 3)\, Sandrine Dabernat (team 8)\, Christelle Dussert (team 4) Coralie Genevois (team 4)\, Valérie Lagarde (team 11)\, Magalie Lalanne (team 8)\, Jessica Massière (team 8) \nAnd many other proposals from other SBM Department research laboratories. \nFull day program \nWell done to the organizers! \nArticle in the Sud-Ouest newspaper \nCome along with your family 👨‍👨‍👧‍👦!
URL:https://www.bricbordeaux.com/en/event/research-opens-its-doors-to-you-sbm-department/
LOCATION:Accueil bâtiment Bordeaux Biologie Santé (BBS)\, 2 rue Dr Hoffmann Martinot\, Bordeaux\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/11/journee-gd-public-sbm-vignette.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231011
DTEND;VALUE=DATE:20231014
DTSTAMP:20230710T074647Z
CREATED:20230710T074647Z
LAST-MODIFIED:20230710T074647Z
UID:44673-1696982400-1697241599@www.bricbordeaux.com
SUMMARY:10th edition angiogenesis congress
DESCRIPTION:Le 10ᵉ congrès de la Société Française d’Angiogenèse (SFA) se déroulera du mercredi 11 au vendredi 13 Octobre 2023 sur le site prestigieux du Haut Carré de l’université de Bordeaux. \nFind among the scientific committee members of the BRIC: Géraldine SIEGFRIED (Team 02) and Thomas MATHIVET (Team 01) \nFurther information
URL:https://www.bricbordeaux.com/en/event/10th-edition-angiogenesis-congress/
LOCATION:Agora du Haut Carré – Université de Bordeaux\, 43 rue Pierre Noailles\, Talence\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/07/capture-decran-2023-07-10-094130.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231006T140000
DTEND;TZID=Europe/Paris:20231006T170000
DTSTAMP:20231010T131943Z
CREATED:20231005T134351Z
LAST-MODIFIED:20231010T131943Z
UID:44600-1696600800-1696611600@www.bricbordeaux.com
SUMMARY:Thesis defense Audrey Michot\, team 9 - SARCOTARGET
DESCRIPTION:Genetics thesis defense directed by François Le Loarer\, \nAudrey Michot\, team 9 SARCOTARGET \nProjet PériSARC : Identification de facteurs morphologiques et moléculaires prédictifs de rechute dans les sarcomes des tissus mous des membres et de la paroi du tronc. \n7e étage Institut Bergonié\, 229 cours de l’Argonne\, Bordeaux. \nProject description at this link
URL:https://www.bricbordeaux.com/en/event/thesis-defense-audrey-michot-team-9-sarcotarget/
CATEGORIES:Meetings,News,Thesis defenses
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/10/soutenance-de-these-audrey-michot.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231005
DTEND;VALUE=DATE:20231006
DTSTAMP:20230703T130028Z
CREATED:20230703T130028Z
LAST-MODIFIED:20230703T130028Z
UID:44063-1696464000-1696550399@www.bricbordeaux.com
SUMMARY:1st Young Scientist Cancer Congress - CGSO - Toulouse
DESCRIPTION:The CRCT postdocs association was created in 2022 by Benoît Aliaga\, Chloé Bessière and Steffen Fuchs. It gathers the 31 postdocs who are currently present in our research center. We decided to organize the 1st Young Scientist Cancer Congress of the Cancéropôle Grand Sud Ouest (GSO) on the 5th October 2023 at the Oncopole\, Toulouse. \nAim: The main goals of this day are to promote the work of the GSO postdocs and young clinician scientists\, to network\, and to optimize their career paths.\nPublic: To achieve our goals\, we decided to open the conference to the whole scientific community of the GSO\, which are researchers and clinicians of all career levels.\nOrganization: This day will alternate presentations by internationally renowned keynote speakers\, presentations by postdocs from the GSO\, an application-focused presentation by a leading single-cell sequencing company and a presentation from an editor of Nature Communications about scientific publishing and peer-reviewing. \nInvited keynote speakers :   \n\nFrancesco Iorio (Wellcome Sanger Institute\, Cambridge / Human Technopole\, Milan\, Italy)\nOlivier Delattre (Institut Curie\, Paris\, France)\nManel Esteller (Josep Carreras Leukaemia Research Institute\, Barcelona\, Spain)\nKathryn McGinnis\, Associate Editor (Nature Communications\, London\, UK)\n\nDeadline for submission of abstracts for oral presentations: July 13\, 2023\nDeadline for submission of abstracts for poster presentations: September 08\, 2023\nRegistration (obligatory) until: September 08\, 2023 \nAll informations at this link \nBenjamin Bonnard\, post-doc in our team 3 is member of the organizer team.
URL:https://www.bricbordeaux.com/en/event/1st-young-scientist-cancer-congress-cgso-toulouse/
LOCATION:Oncopole Toulouse
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/05/young-scientist-cancer-congress-toulouse.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230928
DTEND;VALUE=DATE:20230930
DTSTAMP:20230926T165213Z
CREATED:20230925T162117Z
LAST-MODIFIED:20230926T165213Z
UID:44558-1695859200-1696031999@www.bricbordeaux.com
SUMMARY:1st Enlight Cancer days
DESCRIPTION:Our unit is organizing the 1st meeting of the Enlight Cancer network on Thursday and Friday\, September 28-29\, 2023 \nThe Enlight network (European university Network to promote equitable quality of Life\, sustaInability and Global engagement through Higher education Transformation) is made up of European universities\, including the University of Bordeaux. Within this framework\, our unit is developing the Enlight cancer network. For these two days\, we are inviting members of 4 universities in the network: Ghent\, Galway\, Göttingen and the Basque Country\, so there will be plenty of opportunities for collaboration. \nThis event is reserved for BRIC members and invited scientists from partner universities. \nThanks to the event’s sponsors: Enlight\, Collège des écoles doctorales Université de Bordeaux\, Bristol Myers Squibb\, Casden\, Stilla\, Bordeaux Tourism & Convention. \nThis work was supported by a grant from the French government\, managed by the Agence Nationale de Recherche (ANR) as part of the future investment program\, under reference ANR-20-GURE-0006 (Action: Grandes Universités de recherche / Project acronym: ENLIGHT)\, awarded as part of the APP “Université de Bordeaux – ENLIGHT Seed-funding”. \n \n 
URL:https://www.bricbordeaux.com/en/event/1st-cancer-enlight-days/
CATEGORIES:Meetings,News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/09/enlight-cancerc-days-20231.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230426
DTEND;VALUE=DATE:20230427
DTSTAMP:20230428T082910Z
CREATED:20230426T082749Z
LAST-MODIFIED:20230428T082910Z
UID:43220-1682467200-1682553599@www.bricbordeaux.com
SUMMARY:Financing of the PORPHYRIA project by SATT Aquitaine
DESCRIPTION:SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions\, from the stage of research results to pre-industrialization (proof of concept)\, and to support them until they are brought to market. \nHead by Pr Emmanuel RICHARD\, PU-PH\, head of the biochemistry department at Bordeaux University Hospital and member of theteam 08 – Biotherapies Genetics and Oncology (BioGO)in collaboration with Dr Oscar MILLET of the CICBioGUNE \, Bilbao\, the project PORPHYRIA aims to develop a pharmacological therapeutic option for erythropoietic porphyrias\, a group of rare diseases of heme metabolism. The objective of the €568\,000 investment by SATT Aquitaine is to identify and validate in-vitro and in-vivo a pharmacological inhibitor of the ALAS2 enzyme\, previously identified as a therapeutic target by the BioGO team. \nMore information at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-porphyria-project-by-satt-aquitaine/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/financement-satt-biogo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230322
DTEND;VALUE=DATE:20230323
DTSTAMP:20230328T144510Z
CREATED:20230328T144510Z
LAST-MODIFIED:20230328T144510Z
UID:42854-1679443200-1679529599@www.bricbordeaux.com
SUMMARY:Role of mitochondria in tumors - Quote from C. Grosset in Science et Médecine - Le monde
DESCRIPTION:Christophe Grosset was interviewed by Florence Rosier\, Journalist in the newspaper Le Monde\, about an American study on the spatial mapping of the mitochondrial network and the bioenergetic activity of tumor cells in lung cancer. This work\, which follows that of Christophe Grosset\, in the journal Communications Biology of December 2021\, opens the way to the study of the 3D architecture of tumor tissues and to a better understanding of its role in the development of tumor tissues and resistance to treatment. \nThe article can be found on page 2 of “Science et Médecine – Le Monde” of March 22\, 2023
URL:https://www.bricbordeaux.com/en/event/role-of-mitochondria-in-tumors-quote-from-c-grosset-in-science-et-medecine-le-monde/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230322
DTEND;VALUE=DATE:20230323
DTSTAMP:20230327T134251Z
CREATED:20230327T134251Z
LAST-MODIFIED:20230327T134251Z
UID:42826-1679443200-1679529599@www.bricbordeaux.com
SUMMARY:Focus on recent work on hepatoblastoma and adult liver cancer - team 03
DESCRIPTION:The Department of Biological and Medical Sciences presents a focus on the latest publication of the 03 team– Liver Cancers and Tumor Invasion. \nArticle published in JHEP Reports “Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1” \nFocus of the department to read at this link
URL:https://www.bricbordeaux.com/en/event/focus-on-recent-work-on-hepatoblastoma-and-adult-liver-cancer-team-03/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230321
DTEND;VALUE=DATE:20230322
DTSTAMP:20230424T155224Z
CREATED:20230424T155224Z
LAST-MODIFIED:20230424T155224Z
UID:43207-1679356800-1679443199@www.bricbordeaux.com
SUMMARY:Financing of the G-Stat MIRCADE project by SATT Aquitaine
DESCRIPTION:SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions\, from the stage of research results to pre-industrialization (proof of concept)\, and to support them until they are brought to market. \nLead by Christophe Grosset\, Inserm research director and head of theTeam 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers.\, the GSTAT project offers a new therapeutic option for the treatment of an incurable solid tumor in children\, the infiltrating glioma of the brain stem.\nThe objective of SATT Aquitaine’s €641\,000 investment is to formulate and test the drug candidate in-vitro and in-vivo using the molecules identified during the research team’s work. \nMore information at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-g-stat-mircade-project-by-satt-aquitaine/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/financement-satt-mircade-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230318
DTEND;VALUE=DATE:20230319
DTSTAMP:20230327T141645Z
CREATED:20230327T141645Z
LAST-MODIFIED:20230327T141645Z
UID:42833-1679097600-1679183999@www.bricbordeaux.com
SUMMARY:Links between vaccines and cancer: "We\, oncologists\, refute this theory".
DESCRIPTION:A collective of about 50 oncologists refute claims that Covid vaccination increases the risk of developing or worsening cancer. \nPr. Jacques Robert (team 02) is one of the editors and Dr. Frederic Delom (team 02) is one of the signatories. \nTribune in l’Express to read here \nIllustration afp.com/Fred TANNEAU
URL:https://www.bricbordeaux.com/en/event/links-between-vaccines-and-cancer-we-oncologists-refute-this-theory/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration-afp-fred-tanneau-capture.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230215
DTEND;VALUE=DATE:20230216
DTSTAMP:20230217T154530Z
CREATED:20230217T154530Z
LAST-MODIFIED:20230217T154530Z
UID:42650-1676419200-1676505599@www.bricbordeaux.com
SUMMARY:International Childhood Cancer Day - Christophe Grosset at the National Assembly
DESCRIPTION:On the occasion of the international day of fight against childhood cancers\, the Federation Grandir Sans Cancer\, Mrs. Béatrice DESCAMPS (Deputy of the North) and Mr. Paul CHRISTOPHE (Deputy of the North) organized on Wednesday\, February 15\, 2023 at the National Assembly a lunch of exchanges dedicated to this subject. This event brought together MPs\, associations\, parents\, researchers and professionals (doctors\, social workers\, teachers…) involved in this fight for the lives of children. Christophe Grosset\, head of team 6 MIRCADE (Methods and Innovations for Research on Childhood Cancers) was present to represent the research and\, in particular\, to discuss the subject of the valorization of academic research in pediatric oncology through the BPI-France structure. \nWithin the framework of the International Childhood Cancer Day\, the MIRCADE team opens the doors of its laboratory on 22/02. Information at this link
URL:https://www.bricbordeaux.com/en/event/international-childhood-cancer-day-christophe-grosset-at-the-national-assembly/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/assemblee-nationale.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230204
DTEND;VALUE=DATE:20230205
DTSTAMP:20230206T102044Z
CREATED:20230206T102044Z
LAST-MODIFIED:20230206T102044Z
UID:42569-1675468800-1675555199@www.bricbordeaux.com
SUMMARY:Labeling "Ligue contre le Cancer" of the team 03
DESCRIPTION:On this World Cancer Day\, we are very pleased to announce the labeling by the Ligue contre le cancer of team 03 – Liver Cancers and Tumor Invasion directed by Violaine Moreau and Frederic Saltel. \n\nThank you to the League\, donors and volunteers!
URL:https://www.bricbordeaux.com/en/event/labeling-ligue-contre-le-cancer-of-the-team-03/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/equipe-03--cancers-du-foie-et-invasion-tumorale.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230120
DTEND;VALUE=DATE:20230121
DTSTAMP:20230206T153018Z
CREATED:20230206T153018Z
LAST-MODIFIED:20230206T153018Z
UID:42584-1674172800-1674259199@www.bricbordeaux.com
SUMMARY:Figaro article - CRISPR - F. Moreau-Gaudry and A. bedel intervention
DESCRIPTION:Pr François Moreau-Gaudry and Dr Aurélie Bedel of Team 8 – Genetic Biotherapies and Oncology (BioGO)\, specialists in the study of genotoxicity induced by CRISPR-Cas9 testify in the Figaro article of 20/01/2023 on CRISPR technology.\n\n“The CRISPR revolution keeps its promises“\, headlines Le Figaro. Ten years after its discovery\, the genome editing tool has opened up exciting prospects for medicine. « The applications of CRISPR are too numerous to list extensively »\,notes American Jennifer Doudna\, a professor at the University of California\, Berkeley\, who developed the technique with Frenchwoman Emmanuelle Charpentier\, director of the Max Planck Research Center for Pathogen Science in Berlin. Jennifer Doudna publishes an article in the journal Science reviewing the last ten years of CRISPR-Cas9 technology. But as with any medical innovation\, however exciting it may be\, there are undesirable effects to be feared\, or at least monitored. This is the expertise developed by the Inserm team of Prof. François Moreau-Gaudry and Dr. Aurélie Bedel (U1312 Biotherapies of genetic diseases and cancers) at the University of Bordeaux. « Very quickly\, it was observed that CRISPR was less precise than expected: this is called the ‘off-target’ effect\, i.e. the scissors sometimes hit the wrong target or cause changes in the chromosome\,» explains Prof. Moreau-Gaudry. « This is of concern to us because these are molecular events that are found in cancer »\, explains Aurélie Bedel. This does not imply the suspension of ongoing trials\, she adds.\nExtract from the Inserm press review of 20/01\n\n\nLink to the online article.\nLink to the pdf of the article.\nBioGO team page.
URL:https://www.bricbordeaux.com/en/event/figaro-article-crispr-f-moreau-gaudry-and-a-bedel-intervention/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/figaro-20-01-2023-crispr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230119
DTEND;VALUE=DATE:20230120
DTSTAMP:20230202T155034Z
CREATED:20230202T143819Z
LAST-MODIFIED:20230202T155034Z
UID:42549-1674086400-1674172799@www.bricbordeaux.com
SUMMARY:Focus of the SBM Department on Lucie Brisson and Thomas Mathivet
DESCRIPTION:In the last newsletter of the Department of Biological and Medical Sciences of the University of Bordeaux :\n👉Presentation of Lucie Brisson and Thomas Mathivet\, two Inserm CRs\, co-leaders of team 01 (Tumor and Vascular Biology Laboratory) and recently recruited in our U1312-BRIC unit
URL:https://www.bricbordeaux.com/en/event/focus-of-the-sbm-department-on-lucie-brisson-and-thomas-mathivet/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/lucie-brisson-et-thomas-mathivet.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230116
DTEND;VALUE=DATE:20230117
DTSTAMP:20230126T165547Z
CREATED:20230126T164520Z
LAST-MODIFIED:20230126T165547Z
UID:42481-1673827200-1673913599@www.bricbordeaux.com
SUMMARY:Oncosphere International Congress - BRIC participations
DESCRIPTION:The international congress of the Oncosphere was held on January 12 and 13\, 2023 in Bordeaux gathering more than 250 scientists around cancer research. Many scientists from our unit presented their work or participated in the moderation of the sessions. \nCongratulations to Camille Dantzer\, PhD student in team 3 who won the prize for the best flash-posters! \nhttps://oncospheremeeting.com/ \nThese two days of congress will be available soon in replay. Thanks to Oncosphere Nouvelle-Aquitaine and its supporters for the organization of this conference rich in exchanges.
URL:https://www.bricbordeaux.com/en/event/oncosphere-international-congress-bric-participations/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/image-en-avant.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221109
DTEND;VALUE=DATE:20221110
DTSTAMP:20230112T145342Z
CREATED:20230112T145342Z
LAST-MODIFIED:20230112T145342Z
UID:42398-1667952000-1668038399@www.bricbordeaux.com
SUMMARY:Financing of the LILOK project
DESCRIPTION:Allocation of a €500\,000 grant from the New Aquitaine Region to the Lilok project. \n  \nTheTeam 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers.  has been involved in the LILOK (Living Lab For Kids) project since its inception and is a participant in this 5-year regionally funded project. The team is involved in the “Care and therapies” axis on the theme of “Medical Research” and “Therapies against childhood cancers”.\n \n  \nLILOK’s objective:\n \nPreserve and promote the health of children\, adolescents and youth. \nSummary of the LILOK project: \nThe first pediatric innovation laboratory in France\, LILOK (Living Lab for Kids) aims to accelerate the design and distribution of services and products dedicated to the health of children\, adolescents and young people.\nLILOK brings together players in the field of prevention\, care paths that promote well-being\, excellence in care\, scientific research\, and mental health\, while promoting a healthy and eco-responsible environment.\nLILOK intervenes from the emergence of the need to the industrialization of offers\, contributes to scientific expertise and therapeutic innovation\, transmits a culture of care\, and offers training for health professionals and families.\nIn partnership with local\, academic\, public and private institutional players\, LILOK’s ambition is to be a reference in innovation for children’s health. \nThe MIRCADE team has been part of the LILOK program from the very first day of its creation with the desire to promote and participate in interactions between economic\, academic and associative actors around the issue of childhood diseases\, and particularly pediatric cancers. \n  \nLink to the press article Sud-Ouest – 09/11 \nMore about the Lilok project at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-lilok-project/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/illustrartion-lilok-tiree-agglo-rochelle.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221026
DTSTAMP:20221214T151625Z
CREATED:20221214T150639Z
LAST-MODIFIED:20221214T151625Z
UID:42262-1666656000-1666742399@www.bricbordeaux.com
SUMMARY:Francis Mégraud European Academy of sciences member
DESCRIPTION:Francis Mégraud\, Emeritus Professor Emérite\, team 4 “Helicobacter-associated digestive cancers\, cancer stem cells and therapeutic strategies” has been invited to join the European Academy of sciences – – Life Sciences section\n(Academia Europaea – Section Life Sciences) where it was officially introduced on October 25 in Barcelona.\nThis academy is also concerned with fields other than Life Sciences\, such as Humanities\, Social and Societal Sciences and Exact Sciences.\nIt produces reports on various topics and is called upon to provide advice to the European Union.\nThis year\, 3 Frenchmen were nominated in the Life Sciences section\, including 2 from our University\, the other being Pierre Jaïs\, Director of the IHU Liryc.
URL:https://www.bricbordeaux.com/en/event/francis-megraud-european-academy-of-sciences-member/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/03/francis-megraud.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221014
DTEND;VALUE=DATE:20221015
DTSTAMP:20221021T100550Z
CREATED:20221021T095937Z
LAST-MODIFIED:20221021T100550Z
UID:36063-1665705600-1665791999@www.bricbordeaux.com
SUMMARY:Round table collaboration between patients and researchers
DESCRIPTION:On the occasion of its launch\, the Bordeaux Institute of Oncology (BRIC) organized\, following a series of conferences\, a round table for the general public where patient associations and researchers discussed the importance of their collaboration. \nThis cooperation allows patients to better understand how donations are used\, what the research protocols are\, how to decipher the results obtained\, what happens to biopsies for which they have given their consent\, etc.\nThis collaboration has led to the emergence of the notion of the patient as partner and allows researchers\, through the proximity thus created with patients\, to humanize their daily work by making the scope of their discoveries more tangible. \nhttps://www.canal-u.tv/chaines/univ-bordeaux/collaboration-patientschercheurs \nThe round table is moderated by Yoann Frontout\, science journalist\, with the participation of : \n >> Sophie North Chassande\, teacher-researcher\, University of Bordeaux  \n >> Philippe Souque\, scientific mediator  \n >> Cyril Sarrauste\, co-responsible for the association Mon réseau Cancer Colorectal  \n >> Frédéric Saltel\, Director of Research INSERM\, Director of BRIC  \n >> Christophe Grosset\, INSERM research director\, miRCaDe
URL:https://www.bricbordeaux.com/en/event/round-table-collaboration-between-patients-and-researchers/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/10/image-table-ronde.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220902
DTEND;VALUE=DATE:20220903
DTSTAMP:20220905T085336Z
CREATED:20220902T123543Z
LAST-MODIFIED:20220905T085336Z
UID:20548-1662076800-1662163199@www.bricbordeaux.com
SUMMARY:MIRCADE team. Press article in Inserm Magazine #54
DESCRIPTION:In December 2021\, the team 06 –MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers head by Dr Christophe Grosset published with his collaborators a multidisciplinary article combining 3D imaging\, biology of hepatoblastoma and AI in the journal Communications Biology. \nThe Inserm magazine #54 reviews these major advances in the field of bioarchitectural analysis of tumor tissue\, also called onconanotomy\, with this beautiful article on pages 16 and 17. The entire magazine is available for consultation at this link and the pdf of the article at this link. \n  \nPublication : de Senneville\, Baudouin Denis et al. “Deciphering tumour tissue organization by 3D electron microscopy and machine learning.” Communications biology vol. 4\,1 1390. 13 Dec. 2021\, doi:10.1038/s42003-021-02919-z \nLink to the SBM Departement article about this publication.
URL:https://www.bricbordeaux.com/en/event/mircade-team-press-article-in-inserm-magazine-54/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/09/article-double-page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220901
DTEND;VALUE=DATE:20221001
DTSTAMP:20220901T074528Z
CREATED:20220901T074528Z
LAST-MODIFIED:20220901T074528Z
UID:20516-1661990400-1664582399@www.bricbordeaux.com
SUMMARY:Golden September
DESCRIPTION:Today starts the Golden September\, all together against childhood cancer. \nIt is an opportunity to support all actions in the fight against childhood cancer: comfort for children in hospital\, families in need and research.
URL:https://www.bricbordeaux.com/en/event/golden-september/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/09/capture-decran-2022-09-01-063619.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220720
DTEND;VALUE=DATE:20220721
DTSTAMP:20220720T084457Z
CREATED:20220720T084457Z
LAST-MODIFIED:20220720T084457Z
UID:20276-1658275200-1658361599@www.bricbordeaux.com
SUMMARY:Article about the MIRCADE team - Médical magazine
DESCRIPTION:Focus on the team working on pediatric cancers (Team 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers.)\, led by Christophe Grosset in the June issue of “Médical magazine” (p17).
URL:https://www.bricbordeaux.com/en/event/article-about-the-mircade-team-medical-magazine/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/07/article-mircade-medical-magazine-titre.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220707T173000
DTEND;TZID=Europe/Paris:20220707T190000
DTSTAMP:20220630T135110Z
CREATED:20220630T135110Z
LAST-MODIFIED:20220630T135110Z
UID:20132-1657215000-1657220400@www.bricbordeaux.com
SUMMARY:Cutaneous Lymphoma Webinar - ELLYE - M. Beylot-Barry presentation
DESCRIPTION:Webinar organized by ELLYE : Ensemble Leucemie Lymphomes Espoir \nAll information and registration are at this link: https://app.livestorm.co/ellye-lymphomes-cutanes/webinaire-lymphomes-cutanes \nNote the intervention of Marie Beylot-Barry\, co-leader ofTeam 05 – Translational Research In Oncodermatology and Orphan skin diseases (TRIO2). \nTitle of the speech: Traitements des lymphomes cutanés : Topiques\, oraux et injectables. Comment\, pourquoi ? Évolution de la réglementation et « liste en sus » \nAsk your questions now: infos@ellye.fr
URL:https://www.bricbordeaux.com/en/event/cutaneous-lymphoma-webinar-ellye-m-beylot-barry-presentation/
LOCATION:visio
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/webinaire-lymphome-cutanes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220707
DTEND;VALUE=DATE:20220708
DTSTAMP:20220713T102703Z
CREATED:20220713T102231Z
LAST-MODIFIED:20220713T102703Z
UID:20225-1657152000-1657238399@www.bricbordeaux.com
SUMMARY:Hémangiome-Propranolol publication\, team TRIO2
DESCRIPTION:Read the article written by Candice Ménégon for the SBM Department on the recent publication of theTeam 05 – Translational Research In Oncodermatology and Orphan skin diseases (TRIO2). head by Hamid-Reza Rezvani and Marie Beylot-Barry. \nThe opportunity to focus on research conducted on cutaneous infantile hemangioma and its treatment with propranolol. \nLink to the SBM Department communication \nScientific article: Kaulanjan-Checkmodine\, Priscilla et al. “Is Infantile Hemangioma a Neuroendocrine Tumor?.” International journal of molecular sciences vol. 23\,9 5140. 5 May. 2022\, doi:10.3390/ijms23095140
URL:https://www.bricbordeaux.com/en/event/hemangiome-propranolol-publication-team-trio2/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/07/focus-article-trio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220704T160000
DTEND;TZID=Europe/Paris:20220704T170000
DTSTAMP:20220622T074005Z
CREATED:20220622T074005Z
LAST-MODIFIED:20220622T074005Z
UID:20015-1656950400-1656954000@www.bricbordeaux.com
SUMMARY:SBM Department Seminar - Alina Chan
DESCRIPTION:Alina Chan\, Broad Institute of MIT & Harvard\, will speak on July 4th at 4pm by videoconference. \nInvited by Andreas Bikfalvi\, team leader of Team 01 – Tumor and vascular biology laboratory. \n“The Origines of COVID-19” \nDr. Alina Chan is a co-author of the book\, VIRAL: The Search for the Origin of Covid-19\, and a researcher with a background in medical genetics\, synthetic biology\, and vector engineering. At the Broad Institute of MIT & Harvard\, Dr. Chan is currently creating next generation vectors for human gene therapy. During the COVID-19 pandemic\, Dr. Chan began to investigate problems relevant to finding the origins of the SARS-CoV-2 virus and in parallel spearheaded the development of the COVID-19 CoV Genetics (covidcg.org) browser for scientists worldwide to rapidly track virus lineages and mutations by locations and date ranges of interest. Her talk will focus on what we know about the origins of COVID. The seminar should be very interesting for everyone.
URL:https://www.bricbordeaux.com/en/event/sbm-department-seminar-alina-chan/
LOCATION:Visio A. Chan
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/seminaire-alina-chan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220628T150000
DTEND;TZID=Europe/Paris:20220628T160000
DTSTAMP:20220622T074336Z
CREATED:20220616T102918Z
LAST-MODIFIED:20220622T074336Z
UID:19923-1656428400-1656432000@www.bricbordeaux.com
SUMMARY:SBM Department Seminar - Sabine Colnot
DESCRIPTION:Sabine Colnot\, Centre de Recherche des Cordeliers\, Paris\, will speak on June 28 at 3:00 pm\, amphitheater 11\, Carreire campus. \nInvited by Violaine Moreau\, team leader of theTeam 03 – Liver Cancers and Tumor Invasion. \n“CRISPR-Cas9-engineered mice developing liver cancers with beta-catenin mutation: towards a better understanding of liver carcinogenesis” \nOne third of hepatocellular carcinoma (HCC) have mutations activating beta-catenin signaling. We definitely showed that these mutations are oncogenic in mice (Loesch et al.\, J Hepatol 2022)\, and are responsible for the development of HCC and mesenchymal hepatoblastoma. This mouse model and a previous one obtained through a loss of function of Apc are valuable preclinical models to better understand why a large subset of beta-catenin activated HCCs are resistant to immunotherapies. Our work further supports the hypothesis that they could be treated based on their metabolism (Gougelet et al.\, Gastroenterol 2019; Senni et al.\, Gut 2019). Lastly\, the CRISPR-Cas9 strategy appears to be an easy-to-use approach to investigate the oncogenic function of specific mutations in HCC.
URL:https://www.bricbordeaux.com/en/event/sbm-department-seminar-sabine-colnot/
LOCATION:Amphithéâtre 11\, campus Carreire\, 146 rue Léo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/sabine-colnot.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220621T140000
DTEND;TZID=Europe/Paris:20220621T150000
DTSTAMP:20220623T083317Z
CREATED:20220616T103519Z
LAST-MODIFIED:20220623T083317Z
UID:19927-1655820000-1655823600@www.bricbordeaux.com
SUMMARY:SBM Department Seminar: Andreas Bikfalvi
DESCRIPTION:Andreas Bikfalvi\, Head of Team 01 – Tumor and Vascular Biology Laboratory. \n“The notion of Truth in the Biomedical Sciences” \nThe notion of truth has been debated extensively by philosophers and scientists alike for centuries. Relativist and absolutist/objectivist philosophies have a complete different understanding of the value attached to this notion. In this presentation\, I will discuss a number of issues related to the notion of truth in the biomedical sciences. I will first lay out different meanings and forms of truth and then discuss how this relates to the notion of causality. I will then describe how the biomedical science produces “truth” and lay down the different ways to achieve this (induction\, causal inference\, falsification\, Baysian approach\, etc..). \nI will then illustrate this by citing examples from the medical history and present-day biomedical research related to infectious disease\, vascular biology and cancer research. I will then show that a strong relativist epistemology is incompatible with the way biomedical science obtains knowledge. Thus\, in my view\, a realistic notion of truth is central to achieve a sound understanding of physiology and pathology\, and for the development of therapies grounded in a correct knowledge of disease. \nJune 21 at 2 p.m.\, IBGC conference room\, Carreire. \nPhoto ©Gautier DUFAU \nThe recording is online!
URL:https://www.bricbordeaux.com/en/event/sbm-department-seminar-andreas-bikfalvi/
LOCATION:salle de conférence IBGC – Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/photo-a.-bikfalvi-@gautier-dufau.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220617T133000
DTEND;TZID=Europe/Paris:20220617T140000
DTSTAMP:20220616T103704Z
CREATED:20220616T103647Z
LAST-MODIFIED:20220616T103704Z
UID:19928-1655472600-1655474400@www.bricbordeaux.com
SUMMARY:Techno presentation: CYTENA - CELLCYTE X presentation - Full live cell imaging solution
DESCRIPTION:Presentation organized by the BRIC technology group. \npdf document to consult : CELLCYTE X Features & Benefits \nCYTENA – CELLCYTE X presentation – Full live cell imaging solution. \n\nJim Engström\, Field Application Specialist\nJulia Cantarini\, Technical Sales Specialist – Live Cell Analysis – Central Europe\n\nBy videoconference zoom : ID de réunion : 895 4582 4767
URL:https://www.bricbordeaux.com/en/event/techno-presentation-cytena-cellcyte-x-presentation-full-live-cell-imaging-solution/
LOCATION:visio
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/cytena.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220617
DTEND;VALUE=DATE:20220618
DTSTAMP:20220721T101432Z
CREATED:20220721T101432Z
LAST-MODIFIED:20220721T101432Z
UID:20293-1655424000-1655510399@www.bricbordeaux.com
SUMMARY:Donation of Noéline’s parents to the MIRCADE team for the research on diffuse intrinsic pontine glioma (DIPG)
DESCRIPTION:The association “Noeline\, my daughter\, my battle” was created to raise funds to allow Noeline\, 9 years old\, diagnosed with a diffuse intrinsic pontine glioma (DIPG)\, to follow an innovative treatment in clinical trial in the United States. Unfortunately\, Noeline passed away on March 22\, 2022\, 8 months after her diagnosis. As Noeline could not benefit from this treatment\, her parents decided to donate the funds collected to GITC research. Thus\, on June 17\, 2022\, theteam 06 – MIRCADE (Methods and Innovations for Research on Childhood Cancers)\, led by Christophe Grosset received a check for nearly 21 000 € from the association. This donation will be used to finance expenses related to the project of Guillaume Herrault\, a PhD student\, who started his thesis under the supervision of Christophe Grosset in October 2021 after 5 months as a Master 2 student. \nRead the article published in the Dauphiné Libéré on July 2 : https://www.ledauphine.com/sante/2022/07/02/isere-le-pont-de-claix-noeline-une-cagnotte-au-profit-de-la-recherche-contre-le-cancer \nThe Facebook page of the association Noéline\, ma fille\, ma bataille : https://www.facebook.com/No%C3%A9line-ma-fille-ma-bataille-100170252409146
URL:https://www.bricbordeaux.com/en/event/donation-of-noelines-parents-to-the-mircade-team-for-the-research-on-diffuse-intrinsic-pontine-glioma-dipg/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/07/donation-noeline-mircade.jpg
END:VEVENT
END:VCALENDAR